COMMUNIQUÉS West-GlobeNewswire

-
Shire Announces FDA Approval of TAKHZYRO™ (lanadelumab-flyo), a First-of-its-Kind mAb Preventive Treatment for Hereditary Angioedema
24/08/2018 -
Telix Pharmaceuticals, University of Melbourne and Peter Mac to Collaborate on Colorectal Cancer
24/08/2018 -
Advanced Proteome Therapeutics Announces Closing of First Tranche of a Non-Brokered Private Placement
23/08/2018 -
Terry Bradshaw Encourages Patients to “Take the Pledge to Live Well” in New PSA about Rheumatic Disease
23/08/2018 -
Veloxis Increases Share Capital in Connection with Exercise of Warrants
23/08/2018 -
Cerner and Duke Clinical Research Institute Collaborate on Cardiac Risk App
23/08/2018 -
Intellia Therapeutics Presents Progress in Lead In Vivo Program at Cold Spring Harbor Laboratory’s Fourth Meeting on Genome Engineering: The CRISPR-Cas Revolution
23/08/2018 -
Immunomedics Announces Fourth Quarter and Fiscal Year 2018 Results and Provides Corporate Update
23/08/2018 -
ICC Responds to Media Reports
23/08/2018 -
Nova Leap Health Corp. Reports Second Quarter 2018 Financial Results and Provides Corporate Update
23/08/2018 -
Synergy CHC Corp. Announces Canadian Retail Expansion
23/08/2018 -
RMMI Corp. Announces Filing of Its Financial Statements and Related Management Discussion and Analysis for Q2 2018
23/08/2018 -
Inventiva S.A.: Sale of Shares
23/08/2018 -
NeuroMetrix Announces Participation at the 20th Annual Global Investment Conference in New York City September 4 - 6th, 2018
23/08/2018 -
Inventiva S.A.: Sale of Shares
23/08/2018 -
CROSSJECT : Bilan semestriel du contrat de liquidité au 30 juin 2018
23/08/2018 -
Delcath Announces 3rd Independent Safety Review of Randomized Trial Data for Metastatic Ocular Melanoma; Recommended Continuation with no Trial Modification
23/08/2018 -
Scapa Healthcare Granted European Patent for New Hydrocolloid Adhesive Composition
23/08/2018 -
Medifirst Solutions Announces Update for Its Time Machine Laser Division
23/08/2018
Pages